首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1276223

藥物輸送市場——按給藥途徑、應用、使用設施分類——到 2032 年的全球預測

Pharmaceutical Drug Delivery Market - By Route Of Administration, By Application, Facility Of Use - Global Forecast to 2032

出版日期: 2023年04月21日 | 出版商:

Global Market Insights Inc. | 英文 850 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

到 2032 年，全球藥物輸送市場規模將顯著增長。

糖尿病、心血管疾病和關節炎等慢性病的激增導致死亡率上升。據世界衛生組織稱，心血管疾病每年在全世界造成約 1790 萬人死亡。為此，許多醫療機構和製藥公司都在大力投資提高藥效和給藥途徑，行業發展潛力巨大。

整個藥物給藥市場細分為應用、給藥途徑、使用設施和區域。

就給藥途徑而言，到 2032 年，口服給藥的市場規模將顯著增長。傳染病、炎症性疾病和胃腸道疾病的流行增加了對口服給藥的需求。而且，這種給藥途徑成本低廉，對老人和兒童也很方便。

按應用來看，到 2032 年，腫瘤藥物給藥市場預計將增長 8.5% 以上。癌症患病率的增加增加了對引入新的藥物給藥方法的投資。此外，全球許多製藥公司和醫療機構都在大力投資癌症研究，這也有望對該領域的擴張產生積極影響。例如，2023年3月，美國跨國製藥公司輝瑞公司宣布將投資超過430億美元用於癌症研究。

根據使用設施，該行業分為門診手術中心和診所、醫院、家庭護理機構、診斷中心和其他使用設施。從 2023 年到 2032 年，按家庭護理環境劃分的藥物輸送行業預計將以超過 7.5% 的複合年增長率增長。不斷增長的老年人口和慢性病的流行將支持這一細分市場的增長。此外，家庭保健具有成本效益，正在被採用。

按地區劃分，亞太地區的藥物輸送行業預計從 2023 年到 2032 年將以顯著的複合年增長率增長。行業參與者增加對產品創新研發的投資有助於該地區的增長。此外，幾個區域經濟體的政府也在大力投資擴大醫療保健基礎設施，這將進一步促進區域擴張。根據 Invest India 的數據，到 2030 年，印度的醫療保健行業可能達到 1880 億美元。

內容

第一章調查方法及範圍

第 2 章執行摘要

第 3 章藥物給藥市場洞察

行業細分
2018-2032 年行業格局
影響行業的因素
- 司機
  - 慢性病患病率上升
  - 生物製品市場的增長
  - 技術進步和新產品發布
  - 擴大對醫藥研發的投資
  - 自我管理和家庭護理
- 行業潛在的風險和挑戰
  - 針刺傷的風險

昂貴的藥物開發過程

增長潛力分析
- 按給藥途徑
- 通過使用
- 按設施
COVID-19 影響分析
監管狀況
波特分析
PESTLE 分析

第 4 章競爭格局，2022 年

簡介
公司矩陣分析，2022 年
2022 年競爭對手定位矩陣
公司股票分析，2022 年
戰略願景矩陣，2022 年
戰略儀表板，2022 年

第 5 章藥物給藥市場：按給藥途徑

主要細分市場的趨勢
口服給藥
- 固體口服藥
  - 藥片
  - 膠囊
  - 粉末
  - 藥片
- 液體口服製劑
  - 糖漿
  - 解決方案
- 半固體口服藥物
  - 凝膠
  - 乳液
  - 長生不老藥
注射給藥
- 常規注射器
  - 按材料
    - 玻璃注射器
    - 塑料注射器
  - 按產品分類
    - 可填充注射器
    - 預裝注射器
  - 使用感受
    - 可重複使用的注射器
    - 一次性注射器
- 自動注射器
  - 無針注射器
  - 自動注射器
  - 注射筆
  - 可穿戴注射器
- 其他注射器
本地藥物輸送
- 液體製劑
  - 解決方案
  - 暫停
- 半固體製劑
  - 奶油色
  - 凝膠
  - 藥膏
  - 粘貼
  - 乳液
- 固體製劑
  - 壓瘡
  - 粉末
- 透皮製劑
  - 透皮貼劑
  - 透皮凝膠
眼科藥物輸送
- 液體製劑
  - 眼藥水
  - 噴液
- 半固體製劑
  - 凝膠
  - 眼藥膏
- 眼科設備
  - 藥物塗層隱形眼鏡
  - 眼科插入物
呼吸藥物輸送
- 固定劑量吸入器
- 乾粉吸入器
- 霧化器
  - 噴射霧化器
  - 超聲波霧化器
  - 軟霧霧化器
鼻腔給藥
- 滴鼻劑
- 滴鼻劑
- 粉末
- 鼻用凝膠
經粘膜給藥
- 口服配方
  - 頰側分娩
  - 舌下給藥
- 其他口服給藥技術
  - 直腸分娩
  - 陰道內給藥
植入式給藥
- 主動移植
- 被動植入藥物輸送

第 6 章藥物給藥市場：按應用

主要細分市場的趨勢
感染
癌症
心血管疾病
糖尿病
呼吸系統疾病
中樞神經系統疾病
自身免疫性疾病
其他用途

第 7 章藥物給藥市場：按設施

主要細分市場的趨勢
醫院
門診手術中心/診所
家庭醫療機構
診斷中心
用於其他目的的設施

第 8 章藥物給藥市場：按地區劃分的趨勢

主要區域趨勢
北美
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 意大利
- 瑞士
- 其他歐洲
亞太地區
- 中國
- 日本
- 印度
- 澳大利亞
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 墨西哥
- 其他拉丁美洲地區
中東和非洲
- 南非
- 沙特阿拉伯
- 其他中東和非洲地區

第九章公司簡介

Pfizer Inc.
Johnson & Johnson
AbbVie Inc.
Merck & Co., Inc.
Sanofi
Bayer AG
Amgen, Inc
AstraZeneca plc
Eli Lilly and Company
Gilead Science, Inc.

簡介目錄

Product Code: 5565

Global Pharmaceutical Drug Delivery Market size will garner commendable gains through 2032. Surging incidences of chronic diseases such as diabetes, cardiovascular diseases, and arthritis have resulted in increased mortality rates. As per WHO, cardiovascular diseases account for around 17.9 million deaths every year globally. In this regard, many healthcare organizations and pharmaceutical companies are investing notable amounts to boost the efficacy of the medication and its route of administration, creating a broad scope for industry growth.

The overall pharmaceutical drug delivery market is classified into application, route of administration, facility of use, and region.

With respect to the route of administration, the industry share from the oral drug delivery market size will register recognizable growth through 2032. Rising prevalence of infectious, inflammatory, gastrointestinal diseases, and others has increased the demand for oral administration. Moreover, this route of drug administration is also cost-effective and convenient for the elderly and children.

Based on application, the pharmaceutical drug delivery market from the cancer segment will grow at over 8.5% by 2032. Increasing incidences of cancer have increased investments in introducing new pharmaceutical drug delivery methods. Many pharmaceutical companies and healthcare organizations across the globe are investing substantial amounts into cancer research which will also positively affect segment expansion. To illustrate, in March 2023, Pfizer Inc., an American multinational pharmaceutical company, announced over USD 43 billion in cancer research.

Based on the facility of use, the industry is classified into ambulatory surgical centers and clinics, hospitals, home care settings, diagnostic centers, and other facilities of use. The pharmaceutical drug delivery industry from the home care settings segment will grow at more than 7.5% CAGR from 2023 to 2032. Growing geriatric population base and its susceptibility to chronic diseases will support segment growth. Additionally, the high cost-effectiveness of home care settings favors their adoption.

On the regional front, the Asia Pacific pharmaceutical drug delivery industry share will grow at a substantial CAGR from 2023 to 2032. Growing R&D investments by industry players in product innovations are contributing to regional growth. Moreover, the governments across several regional economies are also investing significant amounts into expanding the healthcare infrastructure, which will further work towards regional expansion. As per Invest India, the healthcare industry in India has the potential to reach USD 188 billion by 2030.

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope and definitions
1.3 Base estimates and working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Pharmaceutical drug delivery industry 360 degree synopsis, 2018 - 2032
2.2 Business trends
2.3 Route of administration trends
2.4 Application trends
2.5 Facility of use trends
2.6 Regional trends

Chapter 3 Pharmaceutical Drug Delivery Market Insights

3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Rising prevalence of chronic diseases
  - 3.3.1.2 Growth in the biologics market
  - 3.3.1.3 Technological advancement and new product launches
  - 3.3.1.4 Increasing investment in pharmaceutical R&D
  - 3.3.1.5 Self-administration and home care
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Risk of needlestick injuries

.3.3.2.2. Cost intensive drug development process

3.4 Growth potential analysis
- 3.4.1 By route of administration
- 3.4.2 By application
- 3.4.3 By facility of use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.7 Porter's analysis
3.8 PESTLE Analysis

Chapter 4 Competitive landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive positioning matrix, 2022
4.4 Company market share analysis, 2022
4.5 Strategic outlook matrix, 2022
4.6 Strategy dashboard, 2022

Chapter 5 Pharmaceutical Drug Delivery Market, By Route of Administration

5.1 Key segment trends
5.2 Oral drug delivery
- 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.2.2 Solid oral drugs
  - 5.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.2.2 Tablets
    - 5.2.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.2.3 Capsules
    - 5.2.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.2.4 Powder
    - 5.2.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.2.5 Pills
    - 5.2.2.5.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.2.3 Liquid oral drugs
  - 5.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.3.2 Syrups
    - 5.2.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.3.3 Solutions
    - 5.2.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.2.4 Semi-solid oral drugs
  - 5.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.4.2 Gels
    - 5.2.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.4.3 Emulsions
    - 5.2.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.4.4 Elixirs
    - 5.2.4.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Injectable drug delivery
- 5.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.3.2 Conventional injection devices
  - 5.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.2.2 By material
    - 5.3.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.2.2 Glass syringes
    - 5.3.2.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.2.3 Plastic syringes
    - 5.3.2.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.2.3 By product
    - 5.3.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.3.2 Fillable syringes
    - 5.3.2.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.3.3 Prefilled syringes
    - 5.3.2.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.2.4 By usability
    - 5.3.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.4.2 Reusable syringes
    - 5.3.2.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.4.3 Disposable syringes
    - 5.3.2.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.3.3 Self-injection devices
  - 5.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.3.2 Needle-free injectors
    - 5.3.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.3.3 Autoinjectors
    - 5.3.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.3.4 Pen injectors
    - 5.3.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.3.5 Wearable injectors
    - 5.3.3.5.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.3.4 Other injector devices
  - 5.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.4 Topical drug delivery
- 5.4.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4.2 Liquid formulations
  - 5.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.2.2 Solutions
    - 5.4.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.2.3 Suspensions
    - 5.4.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4.3 Semi-solid formulations
  - 5.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.2 Creams
    - 5.4.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.3 Gels
    - 5.4.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.4 Ointments
    - 5.4.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.5 Pastes
    - 5.4.3.5.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.6 Lotions
    - 5.4.3.6.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4.4 Solid formulations
  - 5.4.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.4.2 Suppositories
    - 5.4.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.4.3 Powders
    - 5.4.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4.5 Transdermal products
  - 5.4.5.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.5.2 Transdermal patches
    - 5.4.5.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.5.3 Transdermal gels
    - 5.4.5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.5 Ocular drug delivery
- 5.5.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.5.2 Liquid formulations
  - 5.5.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.2.2 Eye drops
    - 5.5.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.2.3 Liquid sprays
    - 5.5.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.5.3 Semi-solid formulations
  - 5.5.3.2 Gels
    - 5.5.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.3.3 Eye ointments
    - 5.5.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.5.4 Ocular devices
  - 5.5.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.4.2 Drug-coated contact lenses
    - 5.5.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.4.3 Ocular inserts
    - 5.5.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.6 Pulmonary drug delivery
- 5.6.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.6.2 Metered-dose inhalers
  - 5.6.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.6.3 Dry powder inhalers
  - 5.6.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.6.4 Nebulizers
  - 5.6.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.6.4.2 Jet nebulizers
    - 5.6.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.6.4.3 Ultrasonic nebulizers
    - 5.6.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.6.4.4 Soft mist nebulizers
    - 5.6.4.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.7 Nasal drug delivery
- 5.7.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.7.2 Nasal drops
  - 5.7.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.7.3 Nasal sprays
  - 5.7.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.7.4 Nasal powders
  - 5.7.4.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.7.5 Nasal gels
  - 5.7.5.1 Market size, by region, 2018 - 2032 (USD Million)
5.8 Transmucosal drug delivery
- 5.8.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.8.2 Oral formulations
  - 5.8.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.8.2.2 Buccal drug delivery
    - 5.8.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.8.2.3 Sublingual drug delivery
    - 5.8.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.8.3 Other transmucosal drug delivery technologies
  - 5.8.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.8.3.2 Rectal drug delivery
    - 5.8.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.8.3.3 Vaginal drug delivery
    - 5.8.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.9 Implantable drug delivery
- 5.9.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.9.2 Active implantable drug delivery
  - 5.9.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.9.3 Passive implantable drug delivery
  - 5.9.3.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 6 Pharmaceutical Drug Delivery Market, By Application

6.1 Key segment trends
6.2 Infectious diseases
- 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Cancer
- 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Cardiovascular diseases
- 6.4.1 Market size, by region, 2018 - 2032 (USD Million)
6.5 Diabetes
- 6.5.1 Market size, by region, 2018 - 2032 (USD Million)
6.6 Respiratory diseases
- 6.6.1 Market size, by region, 2018 - 2032 (USD Million)
6.7 Central nervous system disorders
- 6.7.1 Market size, by region, 2018 - 2032 (USD Million)
6.8 Autoimmune diseases
- 6.8.1 Market size, by region, 2018 - 2032 (USD Million)
6.9 Other applications
- 6.9.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 7 Pharmaceutical Drug Delivery Market, By Facility of Use

7.1 Key segment trends
7.2 Hospitals
- 7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 Ambulatory surgical centers and clinics
- 7.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 Home care settings
- 7.4.1 Market size, by region, 2018 - 2032 (USD Million)
7.5 Diagnostic centers
- 7.5.1 Market size, by region, 2018 - 2032 (USD Million)
7.6 Other facilities of use
- 7.6.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 8 Pharmaceutical Drug Delivery Market, By Region

8.1 Key regional trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Switzerland
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East & Africa